Efficacy and safety of PD-1 inhibitors in recurrent or metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens: a systematic review and meta-analysis

Abstract Objective There is a lack of standard salvage treatment options for recurrent or metastatic nasopharyngeal carcinoma (RM-NPC) that has failed platinum-containing regimens. Breakthroughs in immunotherapy have opened up new options for these patients. However, the efficacy and safety of immun...

Full description

Bibliographic Details

Published in:	BMC Cancer
Main Authors:	Jian Luo, Wanying Xiao, Fengyang Hua, Yanqing Cao, Dongxia Wang, Xicheng Wang
Format:	Article
Language:	English
Published:	BMC 2023-11-01
Subjects:	Recurrent or metastatic nasopharyngeal carcinoma Platinum-containing regimens PD-1 Efficacy Safety
Online Access:	https://doi.org/10.1186/s12885-023-11318-y